Bailard, Inc. Amgen Inc Transaction History

Bailard, Inc.

$3.8 Billion
Q3 2024

A detailed history of Bailard, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Bailard, Inc. holds 46,725 shares of AMGN stock, worth $13.3 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

46,725

Previous 46,863 0.29%

Holding current value

$13.3 Million

Previous $14.6 Million 2.82%

% of portfolio

0.4%

Previous 0.41%

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $42,694 - $46,558	-138 Reduced 0.29%	46,725 $15.1 Million
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $53,863 - $65,458	205 Added 0.44%	46,863 $14.6 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $53,236 - $64,262	-198 Reduced 0.42%	46,658 $13.3 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $317,835 - $358,555	1,243 Added 2.73%	46,856 $13.5 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $1.28 Million - $1.59 Million	5,841 Added 14.69%	45,613 $12.3 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $130,490 - $154,302	609 Added 1.56%	39,772 $8.83 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $216,532 - $263,916	959 Added 2.51%	39,163 $9.47 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $102,605 - $130,372	-448 Reduced 1.16%	38,204 $10 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $1.52 Million - $1.71 Million	6,770 Added 21.23%	38,652 $8.71 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $3.92 Million - $4.36 Million	16,971 Added 113.82%	31,882 $7.76 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $231,768 - $256,396	1,057 Added 7.63%	14,911 $3.61 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $90,092 - $103,102	453 Added 3.38%	13,854 $3.12 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $75,780 - $88,785	-357 Reduced 2.59%	13,401 $2.85 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $132,907 - $147,450	569 Added 4.31%	13,758 $3.35 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $244,101 - $284,460	-1,100 Reduced 7.7%	13,189 $3.28 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $55,609 - $66,221	257 Added 1.83%	14,289 $3.29 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $114,509 - $127,343	488 Added 3.6%	14,032 $3.57 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $768,294 - $942,802	3,884 Added 40.21%	13,544 $3.19 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $46,653 - $61,875	256 Added 2.72%	9,660 $1.96 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $47,680 - $61,286	-252 Reduced 2.61%	9,404 $2.27 Million
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $130,060 - $155,839	747 Added 8.38%	9,656 $1.87 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $7,168 - $8,402	-43 Reduced 0.48%	8,909 $1.64 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $267,868 - $301,946	-1,481 Reduced 14.2%	8,952 $1.7 Million
Q4 2018 Feb 05, 2019	BUY	$178.4 - $208.25 $666,502 - $778,022	3,736 Added 55.79%	10,433 $2.03 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $391,703 - $441,593	2,114 Added 46.13%	6,697 $1.39 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $71,733 - $80,572	-432 Reduced 8.61%	4,583 $846,000
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $59,300 - $69,300	350 Added 7.5%	5,015 $855,000
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $12,321 - $13,767	73 Added 1.59%	4,665 $0
Q2 2017 Aug 11, 2017	SELL	N/A	-295 Reduced 6.04%	4,592 $0
Q1 2017 Jan 29, 2018	BUY	N/A	95 Added 1.98%	4,887 $802,000
Q4 2016 Jan 29, 2018	SELL	N/A	-3,487 Reduced 42.12%	4,792 $0
Q3 2016 Jan 29, 2018	BUY	N/A	970 Added 13.27%	8,279 $1.38 Million
Q2 2016 Jan 29, 2018	BUY	N/A	465 Added 6.79%	7,309 $0
Q1 2016 Jan 29, 2018	BUY	N/A	1,844 Added 36.88%	6,844 $1.03 Million
Q4 2015 Jan 29, 2018	SELL	N/A	-649 Reduced 11.49%	5,000 $0
Q3 2015 Jan 29, 2018	BUY	N/A	1,000 Added 21.51%	5,649 $781,000
Q2 2015 Jan 29, 2018	SELL	N/A	-325 Reduced 6.53%	4,649 $0
Q4 2014 Jan 29, 2018	BUY	N/A	4,974	4,974 $0

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account